Nader E. Abo‐Dya

663 total citations
47 papers, 505 citations indexed

About

Nader E. Abo‐Dya is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Nader E. Abo‐Dya has authored 47 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 24 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Nader E. Abo‐Dya's work include Chemical Synthesis and Analysis (9 papers), Synthesis and biological activity (8 papers) and Click Chemistry and Applications (8 papers). Nader E. Abo‐Dya is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Synthesis and biological activity (8 papers) and Click Chemistry and Applications (8 papers). Nader E. Abo‐Dya collaborates with scholars based in Egypt, Saudi Arabia and United States. Nader E. Abo‐Dya's co-authors include Alan R. Katritzky, Srinivasa R. Tala, Tarek S. Ibrahim, Zakaria K. Abdel‐Samii, Mohammed Issa Alahmdi, İlker Avan, Mahmoud E. S. Soliman, Hong Lü, Asim K. Debnath and Shibo Jiang and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and British Journal of Pharmacology.

In The Last Decade

Nader E. Abo‐Dya

42 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nader E. Abo‐Dya Egypt 13 272 242 53 52 44 47 505
Kavitkumar Patel India 11 214 0.8× 211 0.9× 43 0.8× 34 0.7× 28 0.6× 16 447
Seiya Kitamura United States 15 502 1.8× 525 2.2× 30 0.6× 60 1.2× 26 0.6× 31 904
Dinesh Manvar United States 16 345 1.3× 245 1.0× 92 1.7× 34 0.7× 94 2.1× 31 722
Supaphorn Seetaha Thailand 12 132 0.5× 178 0.7× 39 0.7× 50 1.0× 27 0.6× 30 369
Kazuya Kobayashi Japan 15 317 1.2× 283 1.2× 71 1.3× 74 1.4× 91 2.1× 40 718
Aysun Çapcı Germany 15 358 1.3× 342 1.4× 106 2.0× 84 1.6× 73 1.7× 19 754
Adam Mieczkowski Poland 12 384 1.4× 297 1.2× 32 0.6× 31 0.6× 24 0.5× 45 648
Grigoris Zoidis Greece 17 498 1.8× 303 1.3× 116 2.2× 56 1.1× 40 0.9× 57 961
Ya-Qiu Long United States 19 388 1.4× 407 1.7× 188 3.5× 65 1.3× 33 0.8× 23 818
Xianchao Pan China 13 127 0.5× 164 0.7× 24 0.5× 65 1.3× 68 1.5× 39 402

Countries citing papers authored by Nader E. Abo‐Dya

Since Specialization
Citations

This map shows the geographic impact of Nader E. Abo‐Dya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nader E. Abo‐Dya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nader E. Abo‐Dya more than expected).

Fields of papers citing papers by Nader E. Abo‐Dya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nader E. Abo‐Dya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nader E. Abo‐Dya. The network helps show where Nader E. Abo‐Dya may publish in the future.

Co-authorship network of co-authors of Nader E. Abo‐Dya

This figure shows the co-authorship network connecting the top 25 collaborators of Nader E. Abo‐Dya. A scholar is included among the top collaborators of Nader E. Abo‐Dya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nader E. Abo‐Dya. Nader E. Abo‐Dya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alahmdi, Mohammed Issa, Meshari A. Alsharif, Sayeed Mukhtar, et al.. (2025). Organocatalytic synthesis of novel pyrazoline and pyrimidine derivatives as potent thymidine kinase inhibitors targeting Staphylococcus aureus. Journal of Molecular Structure. 1328. 141427–141427. 3 indexed citations
2.
3.
Metwally, Kamel, Galal Yahya, & Nader E. Abo‐Dya. (2025). Drugging the undruggable: Chemical and biological insights into molecular glues in the pipeline. European Journal of Medicinal Chemistry. 300. 118132–118132.
4.
Abo‐Dya, Nader E., et al.. (2024). New Pyrazole/Pyrimidine-Based Scaffolds as Inhibitors of Heat Shock Protein 90 Endowed with Apoptotic Anti-Breast Cancer Activity. Pharmaceuticals. 17(10). 1284–1284. 4 indexed citations
5.
Alahmdi, Mohammed Issa, Nader E. Abo‐Dya, Peter A. Sidhom, et al.. (2023). Multi-cavity molecular descriptor interconnections: Enhanced protocol for prediction of serum albumin drug binding. European Journal of Pharmaceutics and Biopharmaceutics. 194. 9–19. 6 indexed citations
6.
Abouleisa, Riham, et al.. (2023). A novel small molecule inhibitor of p38⍺ MAP kinase augments cardiomyocyte cell cycle entry in response to direct cell cycle stimulation. British Journal of Pharmacology. 180(24). 3271–3289. 3 indexed citations
7.
Abo‐Dya, Nader E. & Abdul Rashid Issahaku. (2023). Leveraging Flavonoids as Potential Inhibitors of METTL3 in Combating Cancer: A Combined Structure‐Based Drug Design and DFT Approach. ChemistrySelect. 8(45). 2 indexed citations
8.
Metwally, Kamel, Nader E. Abo‐Dya, Mohammed Issa Alahmdi, et al.. (2023). The Unusual Architecture of RNA-Dependent RNA Polymerase (RdRp)’s Catalytic Chamber Provides a Potential Strategy for Combination Therapy against COVID-19. Molecules. 28(6). 2806–2806. 3 indexed citations
9.
10.
11.
Issahaku, Abdul Rashid, Clement Agoni, Mohammed Issa Alahmdi, et al.. (2023). Discovery of Potential KRAS‐SOS1 Inhibitors from South African Natural Compounds: An In silico Approach. ChemistrySelect. 8(24). 33 indexed citations
12.
Metwally, Kamel, Nader E. Abo‐Dya, Ahmed M. Hamdan, et al.. (2023). Investigation of Simultaneous and Sequential Cooperative Homotropic Inhibitor Binding to the Catalytic Chamber of SARS-CoV-2 RNA-dependent RNA Polymerase (RdRp). Cell Biochemistry and Biophysics. 81(4). 697–706.
13.
Issahaku, Abdul Rashid, Clement Agoni, Samuel K. Kwofie, et al.. (2023). Multi-dimensional structural footprint identification for the design of potential scaffolds targeting METTL3 in cancer treatment from natural compounds. Journal of Molecular Modeling. 29(4). 122–122. 12 indexed citations
14.
Abo‐Dya, Nader E., Abdul Rashid Issahaku, Clement Agoni, et al.. (2022). Novel Sunifiram-carbamate hybrids as potential dual acetylcholinesterase inhibitor and NMDAR co-agonist: simulation-guided analogue design and pharmacological screening. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1241–1256. 6 indexed citations
15.
16.
Alahmdi, Mohammed Issa, Rafat M. Mohareb, Mahmoud A. Abdelaziz, et al.. (2021). Anti‐proliferative Activities of Thiophenes, Pyrans and PyridinesDerived from 1,3‐Dicarbonyl Compounds. ChemistrySelect. 6(43). 12094–12100. 4 indexed citations
17.
Ibrahim, Tarek S., Nader E. Abo‐Dya, Nabil A. Alhakamy, et al.. (2020). Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity. Bioorganic Chemistry. 99. 103797–103797. 28 indexed citations
18.
Avan, İlker, et al.. (2013). Photophysics of novel coumarin-labeled depsipeptides in solution: sensing interactions with SDS micelle via TICT model. Amino Acids. 45(1). 159–170. 5 indexed citations
19.
Katritzky, Alan R., et al.. (2010). DBU-Catalyzed transprotection of N-Fmoc-cysteine di- and tripeptides into S-Fm-cysteine di- and tripeptides. Organic & Biomolecular Chemistry. 9(2). 596–599. 8 indexed citations
20.
Katritzky, Alan R., et al.. (2009). An efficient method for the preparation of peptide alcohols. Organic & Biomolecular Chemistry. 7(21). 4444–4444. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kavitkumar Patel Breakdown of academic impact, for papers by Seiya Kitamura Breakdown of academic impact, for papers by Dinesh Manvar Breakdown of academic impact, for papers by Supaphorn Seetaha Breakdown of academic impact, for papers by Kazuya Kobayashi Breakdown of academic impact, for papers by Aysun Çapcı Breakdown of academic impact, for papers by Adam Mieczkowski Breakdown of academic impact, for papers by Grigoris Zoidis Breakdown of academic impact, for papers by Ya-Qiu Long Breakdown of academic impact, for papers by Xianchao Pan
Rankless by CCL
2026